ORTHOWORLD.com
October 2016  
   The Forgotten Phase of M&A: Supply Chain Infrastructure
People, systems, processes...upstream supply chain, downstream supply chain -- these often fall into the "we'll figure it out later" category and are not given attention equivalent to the risk that they pose. In this timely article, David Finch suggests that you add these to your due diligence checklist to assure that you don't miss any critical areas.
  M&A Close-up: 2016 Transactions Year to Date
ORTHOWORLD's M&A Activity database has logged 39 transactions year to date for 2016, already ahead of 2015's whole-year total of 36. A variety of company types are represented (OEM, Supplier, Distributor, Private Equity), and the values range from $10 million to $1 billion. The top five (DePuy, Zimmer Biomet, Stryker, Smith & Nephew and Medtronic) were acquirers in 15 of the 39.
  Postmarket Surveillance and M&A
Data collection is paramount to the success of any orthopaedic device. What happens to the much-coveted postmarket initiative during and after an acquisition?  We posed this question to Vicki Anastasi, Vice President & Global Head, Medical Devices & Diagnostics Research with ICON plc.
 



 
 Strategic Orthopaedic-related 510(k)s issued in September 2016
Each month, ORTHOWORLD examines updates to FDA's orthopaedic-related 510(k) database and highlights those products deemed strategic, defined as a company's first 510(k) clearance, first clearance in a segment that is new to the company, clearance for a type of device not formerly marketed by a company, etc.
  DePuy Synthes/JNJ Posts 3Q16 Revenue
DePuy Synthes posted 3Q16 orthopaedic revenue of US $2,215.0MM, +3.2% vs. 3Q15, as reported. (U.S. $1,343.0MM, +2.4%; ex-U.S. $908.0MM, +4.5%) Click to read  ORTHOWORLD's breakdown by market segment.



Orthopaedic-Specific Mergers, Acquisitions and Technology/License Transfers, January - September 2016
View a snapshot of 2016 transactions by quarter and by type (OEM, Supplier, Private Equity).
 
 
Transaction activity continues in 4Q, as evidenced by these announcements: